Literature DB >> 10087947

PHA/IL2: an efficient mitogen cocktail for cytogenetic studies of non-Hodgkin lymphoma and chronic lymphocytic leukemia.

R Morgan1, Z Chen, K Richkind, S Roherty, J Velasco, A A Sandberg.   

Abstract

This study documents the utility of a mitogen/cytokine cocktail composed of phytohemagglutinin and Interleukin 2 (PHA/IL2) used to stimulate cultures from patients with chronic lymphoproliferative disorders. We report the results of a selected series of 57 patients with non-Hodgkin lymphoma (NHL) or chronic lymphocytic leukemia (CLL), in which only the culture stimulated with PHA/IL2 demonstrated the presence of an abnormal clone. On average, cells in the abnormal clone comprised 40% of the mitotic cells in this culture. The most common abnormalities observed in these patients were trisomy 12, present in 39% of the cases, and t(14;18), seen in 14% of cases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10087947     DOI: 10.1016/s0165-4608(98)00150-2

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  A practical approach to the detection of prognostically significant genomic aberrations in multiple myeloma.

Authors:  Zhong Chen; Bonnie Issa; Shiang Huang; Emily Aston; Jia Xu; Margaret Yu; Arthur R Brothman; Martha Glenn
Journal:  J Mol Diagn       Date:  2005-11       Impact factor: 5.568

2.  Using gene co-expression network analysis to predict biomarkers for chronic lymphocytic leukemia.

Authors:  Jie Zhang; Yang Xiang; Liya Ding; Kristin Keen-Circle; Tara B Borlawsky; Hatice Gulcin Ozer; Ruoming Jin; Philip Payne; Kun Huang
Journal:  BMC Bioinformatics       Date:  2010-10-28       Impact factor: 3.169

3.  Molecular diagnosis of citrin deficiency in an infant with intrahepatic cholestasis: identification of a 21.7kb gross deletion that completely silences the transcriptional and translational expression of the affected SLC25A13 allele.

Authors:  Zhan-Hui Zhang; Wei-Xia Lin; Qi-Qi Zheng; Li Guo; Yuan-Zong Song
Journal:  Oncotarget       Date:  2017-08-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.